Advertisement
Electronic cigarette use is associated with a decrease in tobacco smoke toxicant exposure in those who quit smoking

E-Cigarette Use Cuts Tobacco Smoke Toxicant Exposure

0
Decrease in toxicant exposure for those who quit smoking and for dual users
In a review article published online Sept. 3 in the New England Journal of Medicine

Suggested Response Provided for In-Flight Medical Emergencies

0
Article offers tips for physicians providing emergency in-flight medical care
Irreversible electroporation in pancreatic cancer cells may improve survival rates for some patients

Irreversible Electroporation Promising in Pancreatic Cancer

0
Study found procedure improved survival for people with stage III disease
A minority of colorectal cancer survivors experience social distress

Social Distress ID’d in Minority of Colorectal Cancer Survivors

0
Strongest predictor of social distress is having three or more long-term conditions
Imetelstat

Imetelstat Deemed Active in Myelofibrosis, Thrombocythemia

0
Responses for patients with myelofibrosis, essential thrombocythemia
There has been an increase in the number of American men with cancer in one breast who have surgery to remove their cancer-free breast

More Male Breast CA Patients Having Both Breasts Removed

0
Trend mirrors the one seen in women, researchers say
An experimental therapy for chronic lymphocytic leukemia that uses a patient's own T cells (an approach known as CTL019) may cure some patients and prolong survival in others

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

0
T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells
Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.

Addition of Glitazone to Chemo May Help Treat CML

0
Combining glitazones with standard treatment improved survival in small study
Vietnam veterans exposed to Agent Orange have a more than doubled risk of developing monoclonal gammopathy of undetermined significance

Agent Orange Tied to MGUS in Vietnam Vets

0
Exposed veterans have higher rates of monoclonal gammopathy of undetermined significance
Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

0
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy